Immunoassays: Technologies and Global Markets

Published - Apr 2013| Analyst - Carlet Auguste| Code - BIO033B
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

The global demand for immunoassay testing was nearly $15.6 billion in 2011 and $16.3 billion in 2012. This market is expected to grow to $20.5 billion by 2017, at a compound annual growth rate (CAGR) of 4.7% from 2012 to 2017.

Report Includes

  • An overview of the global market for growth of immunoassay technology in clinical, food safety, and environmental areas.
  • Analysis of global market trends, with data provided for 2011 and 2012, and projections, with five-year compound annual growth rates (CAGRs), through 2017.
  • Discussion of government regulations and technology patents and the roles they play in development.
  • Analysis of new markets.
  • Comprehensive company profiles of major players.

Report Scope

The scope of this study encompasses an investigation of the markets for the following immunoassay testing categories:  enzyme, fluorescence, radio-immunoassay (RIA), cardiac analysis, infectious diseases, and tumor diagnosis.  BCC analyzes each immunoassay examination type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years.  Technological issues including the latest trends are discussed.  BCC analyzes the industry on a worldwide basis, both from an application and demand point of view in the major regions of the world.

Analyst Credentials

Carlet Auguste is president and CEO of Efficiency Engineering Inc., a consulting firm that provides technology engineering services to corporations and nonprofit organizations.  He consults regularly with government and private industry companies from a variety of fields of engineering to help create technology innovations for the private sector as well as government customers needing technology solutions for national defense.  He previously worked for a U.S. government agency in the area of intelligence and security.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Published - Dec-2001| Analyst - Ruth Scolnick| Code - BIO033A

Report Highlights

  • As the human genome-sequencing project nears completion and other organisms' genomes are sequenced, the number of known proteins increases. Many proteins are currently being used and will be used as diagnostic tools in immunoassays. Immunoassays are used in a variety of applications: medical diagnostics, infectious disease testing, drug testing, home use, hormones, veterinary diagnostic, cancer, tissue typing, research, food testing, environmental testing, industrial chemicals, plant disease diagnostics, and biotechnology products testing. Enzyme-linked immunosorbent, chemiluminescent, fluorescent, radio-labeled, and immunoprecipitation are some of the old and new immunoassay technologies being used. New immunoassay technologies are also being developed. Since the number of known proteins and the potential number of immunoassays are increasing, it is interesting to analyze the current and developing immunoassay technologies and markets.
  • This report is an analytical tool whose primary purpose is to show increased growth in the current and emerging clinical, food safety, and environmental immunoassay fields. The report discusses specific, patented technology, the role of government regulation and patents that affect the development and growth of the various immunoassay markets.


Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report